A PHASE 1 STUDY OF SU011248 IN COMBINATION WITH FOLFIRI (IRINOTECAN, 5-FLUOROURACIL AND LEUCOVORIN) IN PATIENTS WITH METASTATIC COLORECTAL CANCER
收藏NIAID Data Ecosystem2026-03-06 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2517000
下载链接
链接失效反馈官方服务：
资源简介：
Primary objectives: To assess the Maximum Tolerated Dose (MTD) and overall safety and tolerability of SU011248 in combination with FOLFIRI
Primary endpoints: Objective Response Rate (ORR)
创建时间：
2005-08-15
